FDA Expands Cheese Recall
Digest more
7hon MSN
Exclusive - US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track program after agency scientists flagged safety and efficacy concerns, including the death of a patient while taking one of the medicines,
Spring & Mulberry chocolate recall expands from one to eight products due to Salmonella fears. Date-sweetened chocolates sold nationwide affected.
Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite assurances of swift reviews under the FDA's new Commissioner’s National Priority Voucher program.
Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels.
Federal regulators say the newly identified products were flagged after state partners detected significant lead transfer from certain aluminum and brass pans.
Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss drugs. The U.S.
The House Democratic Women’s Caucus (DWC) commended the Food and Drug Administration (FDA) and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for lifting the black box warning on estrogen-based products for hormone replacement therapy (HRT).
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
18hon MSN
FDA finds repeat quality failures at Houston's Empower Pharmacy in latest inspection, records show
The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.